Intelligent Bio Solutions Inc. (INBS)

USD 1.27

(-6.62%)

Gross Profit Summary of Intelligent Bio Solutions Inc.

  • Intelligent Bio Solutions Inc.'s latest annual gross profit in 2024 was 1.42 Million USD , up 336.41% from previous year.
  • Intelligent Bio Solutions Inc.'s latest quarterly gross profit in 2024 FY was 1.42 Million USD , up 336.41% from previous quarter.
  • Intelligent Bio Solutions Inc. reported a annual gross profit of 326.66 Thousand USD in annual gross profit 2023, down 0.0% from previous year.
  • Intelligent Bio Solutions Inc. reported a annual gross profit of - USD in annual gross profit 2022, down -100.0% from previous year.
  • Intelligent Bio Solutions Inc. reported a quarterly gross profit of 232.33 Thousand USD for 2024 Q1, up 368.65% from previous quarter.
  • Intelligent Bio Solutions Inc. reported a quarterly gross profit of 199.24 Thousand USD for 2024 Q2, down -14.24% from previous quarter.

Annual Gross Profit Chart of Intelligent Bio Solutions Inc. (2024 - 2017)

Historical Annual Gross Profit of Intelligent Bio Solutions Inc. (2024 - 2017)

Year Gross Profit Gross Profit Growth
2024 1.42 Million USD 336.41%
2023 326.66 Thousand USD 0.0%
2022 - USD -100.0%
2021 1.98 Million USD 949.3%
2020 188.74 Thousand USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%

Peer Gross Profit Comparison of Intelligent Bio Solutions Inc.

Name Gross Profit Gross Profit Difference
Bionano Genomics, Inc. 9.56 Million USD 85.097%
Prenetics Global Limited 8.82 Million USD 83.855%
Star Equity Holdings, Inc. 11.92 Million USD 88.046%
CareDx, Inc 178.32 Million USD 99.201%
Exact Sciences Corporation 1.84 Billion USD 99.923%
Exagen Inc. 29.45 Million USD 95.16%
Inotiv, Inc. 165.44 Million USD 99.138%
Guardant Health, Inc. 336.89 Million USD 99.577%
Biodesix, Inc. 36.07 Million USD 96.048%
BioNexus Gene Lab Corp. 1.32 Million USD -7.23%
Precipio, Inc. 6.01 Million USD 76.311%
iSpecimen Inc. 5.1 Million USD 72.09%
Natera, Inc. 492.74 Million USD 99.711%
Aspira Women's Health Inc. 5.26 Million USD 72.907%
Standard BioTools Inc. 50.45 Million USD 97.174%
23andMe Holding Co. 99.37 Million USD 98.565%
Castle Biosciences, Inc. 174.8 Million USD 99.184%
Personalis, Inc. 18.2 Million USD 92.17%
Aclaris Therapeutics, Inc. 13.16 Million USD 89.174%
Applied DNA Sciences, Inc. 5.53 Million USD 74.236%
OpGen, Inc. -90.69 Thousand USD 1671.908%
T2 Biosystems, Inc. -8.17 Million USD 117.45%
Myriad Genetics, Inc. 476.4 Million USD 99.701%
ICON Public Limited Company 1.81 Billion USD 99.921%
NeoGenomics, Inc. 244.6 Million USD 99.417%
Star Equity Holdings, Inc. 11.92 Million USD 88.046%
IDEXX Laboratories, Inc. 2.18 Billion USD 99.935%
RadNet, Inc. 93 Million USD 98.467%
MDxHealth SA 43.92 Million USD 96.755%
Psychemedics Corporation 8.41 Million USD 83.054%
Illumina, Inc. 2.74 Billion USD 99.948%
Check-Cap Ltd. -212 Thousand USD 772.465%
Twist Bioscience Corporation 133.34 Million USD 98.931%
DarioHealth Corp. 5.98 Million USD 76.176%
Fulgent Genetics, Inc. 104.45 Million USD 98.635%
Sera Prognostics, Inc. 96 Thousand USD -1385.027%
ENDRA Life Sciences Inc. -275.45 Thousand USD 617.561%
OPKO Health, Inc. 318.12 Million USD 99.552%
Medpace Holdings, Inc. 524.5 Million USD 99.728%
Neogen Corporation 463.9 Million USD 99.693%
Prenetics Global Limited 8.82 Million USD 83.855%
Mainz Biomed B.V. 509.65 Thousand USD -179.722%
bioAffinity Technologies, Inc. 791.61 Thousand USD -80.091%
Trinity Biotech plc 19.45 Million USD 92.67%
Neuronetics, Inc. 51.7 Million USD 97.243%
Sotera Health Company 577.15 Million USD 99.753%
bioAffinity Technologies, Inc. 791.61 Thousand USD -80.091%